User profiles for Franco Zunino
Franco ZuninoSNSF Ambizione Fellow, Scientist on Ultra-green concrete @ ETH Zürich, Switzerland Verified email at ethz.ch Cited by 2039 |
Association between Cisplatin Resistance and Mutation of p53 Gene and Reduced Bax Expression in Ovarian Carcinoma Cell Systems
…, D Delia, MA Pierotti, T Miyashita, JC Reed, F Zunino - Cancer research, 1996 - AACR
p53 status may be a determinant of chemosensitivity of tumor cells; however, its involvement
in cellular resistance to cisplatin remains uncertain. To investigate the relationships …
in cellular resistance to cisplatin remains uncertain. To investigate the relationships …
Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development
…, S Tinelli, CA Austin, ML Fisher, F Zunino - … et Biophysica Acta (BBA …, 1992 - Elsevier
The expression of DNA topoisomerase II α and β genes was studied in murine normal tissues.
Northern blot analysis using probes specific for the two genes showed that the patterns of …
Northern blot analysis using probes specific for the two genes showed that the patterns of …
[HTML][HTML] The reaction between metakaolin and limestone and its effect in porosity refinement and mechanical properties
F Zunino, K Scrivener - Cement and Concrete Research, 2021 - Elsevier
… The Swiss federal commission for scholarships for foreign students (FCS) is acknowledged
for supporting Franco Zunino's studies through scholarship 2016.0719. The authors …
for supporting Franco Zunino's studies through scholarship 2016.0719. The authors …
[HTML][HTML] Clay calcination technology: state-of-the-art review by the RILEM TC 282-CCL
The use of calcined clays as supplementary cementitious materials provides the opportunity
to significantly reduce the cement industry’s carbon burden; however, use at a global scale …
to significantly reduce the cement industry’s carbon burden; however, use at a global scale …
Overview of tumor cell chemoresistance mechanisms
L Gatti, F Zunino - Chemosensitivity: Volume II: In VIVO Models, Imaging …, 2005 - Springer
Drug resistance of tumor cells is recognized as the primary cause of failure of
chemotherapeutic treatment of most human tumors. Although pharmacological factors-including …
chemotherapeutic treatment of most human tumors. Although pharmacological factors-including …
Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents
…, L Dal Bo, N Carenini, C Giommarelli, F Zunino - Bioorganic & medicinal …, 2010 - Elsevier
The naturally occurring coumarins and resveratrol, attract great attention due to their wide
range of biological properties, including anticancer, antileukemic, antibacterial and anti-…
range of biological properties, including anticancer, antileukemic, antibacterial and anti-…
SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis
…, C Pisano, P Carminati, M Tortoreto, F Zunino… - Clinical Cancer …, 2011 - AACR
Purpose: Heparanase promotes myeloma growth, dissemination, and angiogenesis through
modulation of the tumor microenvironment, thus highlighting the potential of therapeutically …
modulation of the tumor microenvironment, thus highlighting the potential of therapeutically …
A Comparative Study of p53 Gene Mutations, Protein Accumulation, and Response to Cisplatin-based Chemotherapy in Advanced Ovarian Carcinoma
…, S Oriana, S Böhm, GL Bresciani, G Spatti, F Zunino - Cancer Research, 1996 - AACR
The p53 protein is a multifunctional transcriptional regulator involved in cellular response to
DNA damage and has been implicated as a putative determinant of sensitivity of tumor cells …
DNA damage and has been implicated as a putative determinant of sensitivity of tumor cells …
BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin
…, N Farrell, D Polizzi, R Supino, G Pezzoni, F Zunino - Clinical cancer …, 2000 - AACR
Multinuclear platinum complexes represent a new class of anticancer agents, distinct in
terms of DNA binding features and the profile of antitumor activity from their mononuclear …
terms of DNA binding features and the profile of antitumor activity from their mononuclear …
Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI‐007) Phase I study of patients with squamous …
…, V Tichà, V Vespro, F Zunino - … Journal of the …, 2001 - Wiley Online Library
BACKGROUND This study was designed to determine the feasibility, maximum tolerated
dose, and toxicities of intraarterial administration of paclitaxel‐albumin nanoparticles in …
dose, and toxicities of intraarterial administration of paclitaxel‐albumin nanoparticles in …